Comunicati Stampa
Salute e Benessere

Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight

Key Takeaways from the Carotid Artery Stent Market Report Key Takeaways from the Carotid Artery Stent Market Report To read more about the latest highlights related to the carotid artery stent market, get a snapshot of the key highlights entailed in theGlobal Carotid Artery Stent Market Report Carotid Artery Stent Overview Carotid artery stenting is a minimally invasive procedure used to treat carotid artery disease, a condition where the carotid arteries, located in the...
LAS VEGAS, (informazione.news - comunicati stampa - salute e benessere)

To read more about the latest highlights related to the carotid artery stent market, get a snapshot of the key highlights entailed in the

Carotid artery stenting is a minimally invasive procedure used to treat carotid artery disease, a condition where the carotid arteries, located in the neck, become narrowed or blocked by the buildup of plaque. During the procedure, a slender tube called a catheter is inserted into an artery, usually in the groin, and guided to the carotid artery under X-ray imaging. Once in place, a stent—a small mesh tube—is expanded within the narrowed portion of the artery, pushing aside the plaque and restoring blood flow to the brain. This technique is an alternative to carotid endarterectomy, a surgical procedure that involves opening the carotid artery and removing the plaque.

While carotid artery stenting is less invasive compared to surgery, it's not without risks. Complications can include stroke, bleeding at the puncture site, or the formation of blood clots. However, for certain patients, such as those deemed high-risk for surgery due to other health conditions, or those with difficult-to-reach blockages, carotid artery stenting can be a valuable treatment option. It offers a shorter recovery time and avoids the need for general anesthesia, making it a preferred choice for some individuals. Close monitoring and careful patient selection are crucial to ensure the best possible outcomes.

In 2023, North America dominated the carotid artery stents market, mainly due to the increasing incidence of cardiovascular diseases and associated risk factors like obesity, hypertension, and diabetes. Factors like government initiatives, high disposable income, a growing aging population, and advanced healthcare facilities further drive market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) in 2022, around 18.2 million adults in the US suffer from coronary artery disease, with approximately 805,000 experiencing heart attacks annually, a significant portion being first-time occurrences. Moreover, the elderly population, especially those over 50, are particularly susceptible to carotid artery disease due to age-related arterial changes.

The United States Census Bureau's 2021 report indicates that over 54 million adults aged 65 and older lived in the US, and this demographic is expected to reach 85.7 million by 2050, constituting about 20% of the total population. This aging population contributes to the rising demand for carotid artery stents.

Furthermore, the presence of major industry players like Boston Scientific Corporation, Cordis, and Silk Road Medical Inc. headquartered in North America also bolsters the carotid artery stent market growth in the region. Consequently, the increasing prevalence of cardiovascular diseases and the concentration of key market players are driving the expansion of the carotid artery stent market in North America .

To know more about why North America is leading the market growth in the carotid artery stent market, get a snapshot of the

The carotid artery stent market has seen significant dynamics over the past few years, driven by a . Carotid artery stenting has emerged as a minimally invasive alternative to traditional surgical interventions for treating carotid artery stenosis, offering . As a result, the demand for carotid artery stents has been steadily increasing, particularly among aging populations where vascular diseases are more prevalent.

One of the key drivers shaping the carotid artery stent market dynamics is the by healthcare providers. With advancements in stent design, materials, and delivery systems, carotid artery stenting has become , leading to its wider acceptance as a treatment option. Moreover, the about stroke prevention and early detection of carotid artery diseases has further fueled the demand for stenting procedures.

However, despite these advancements, challenges persist in the carotid artery stent market. Issues such as , necessitating ongoing research and development efforts to improve stent design and minimize complications. Additionally, can impact carotid artery stent market growth, influencing the adoption rates of carotid artery stenting procedures in different regions.

Looking ahead, the carotid artery stent market is poised for continued growth, driven by factors such as an aging population, increasing prevalence of vascular diseases, and ongoing innovations in stent technology. With a focus on improving patient outcomes and reducing procedural risks, manufacturers and healthcare providers are likely to invest further in research, development, and training initiatives to expand the accessibility and efficacy of carotid artery stenting procedures.

Get a sneak peek at the carotid artery stent market dynamics @

 

Which MedTech key players in the carotid artery stent market are set to emerge as the trendsetter explore @  

 

Interested in knowing the carotid artery stent market by 2030? Click to get a snapshot of the

 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Ischemic Stroke companies, including among others.

 report delivers an in-depth understanding of the disease, historical, and forecasted ischemic stroke epidemiology in the 7MM.

report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including among others.

 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key acute ischemic stroke companies, including  among others.

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Shruti Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/global-carotid-artery-stent-market-to-grow-substantially-at-a-cagr-of-3-by-2030--delveinsight-302165611.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili